Paul Barkopoulos, MD.Dr. Barkopoulos has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
How high should we go when dosing antipsychotics in schizophrenia? A recent meta-analysis of 68 studies examined dose-response relationships in randomized controlled trials of antipsychotic medications for schizophrenia and schizoaffective disorder.
The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits.
To all my devoted readers: Welcome to the inaugural issue of the CHPR. This is my fourth CME newsletter, and I wanted to share with you why we’re launching this product. Some of you know that over the past couple of years I have been working full time as the...
The 2021/2022 Carlat Hospital Psychiatry Report Self-Assessment Course includes all 8 newsletter issues from 2021 to 2022 for a total 16 Category 1 CME Credits and 8 ABPN Self-Assessment Credits for Maintenance of Certification. The CME credits are awarded after each activity is completed. The Self-Assessment credits are awarded after all the activities are complete.
KarXT (Cobenfy) is the first antipsychotic that doesn’t block dopamine. We trace the origins of this new drug to a South Asian herb used for over 5,000 years, up to the three...